CCR5 is a clinically relevant target since it serves as a co-receptor of CCR5-tropic human immunodeficiency virus 1 (HIV1), which mediates the primary HIV infection of CD4+ cells in the vast majority of patients. This evidence concerns the gene CD4 and HIV infectious disease.